Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
Top Cited Papers
- 1 September 2001
- journal article
- review article
- Published by Springer Nature in Nature Medicine
- Vol. 7 (9), 987-989
- https://doi.org/10.1038/nm0901-987
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Angiogenic Heterogeneity: Regulation of Neoplastic Angiogenesis by the Organ MicroenvironmentJNCI Journal of the National Cancer Institute, 2001
- Targeting tumor vasculature with homing peptides from phage displaySeminars in Cancer Biology, 2000
- Angiogenesis in cancer and other diseasesNature, 2000
- Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicityJournal of Clinical Investigation, 2000
- Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawalJournal of Clinical Investigation, 1999
- Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: Role of vascular endothelial growth factorProceedings of the National Academy of Sciences, 1998
- The next frontier of molecular medicine: Delivery of therapeuticsNature Medicine, 1998
- Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibodyProceedings of the National Academy of Sciences, 1996
- A systems approach to cancer therapyCancer and Metastasis Reviews, 1996
- Barriers to Drug Delivery in Solid TumorsScientific American, 1994